- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aurisco Pharmaceutical Co Ltd (605116)
Assess today's live Aurisco Pharmaceutical Co Ltd (605116) share price, performance and insights using our live Shanghai: 605116 stock exchange data.
Analyse the historical data and Aurisco Pharmaceutical Co Ltd share price performance charts on this page. Our technical summary section provides analysis on Aurisco Pharmaceutical Co share price buy/sell indicators using real-time data (or discuss the Aurisco Pharmaceutical Co (605116) stock price today with other investors in the Aurisco Pharmaceutical Co SS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SS 605116 share price (ISIN: CNE1000042S4) to enhance your trading decisions with our free investment tools and resources.
What Is the Aurisco Pharmaceutical Co Ltd Share Price Today?
The Aurisco Pharmaceutical Co share price today is 26.72.
What Is the Stock Symbol for Aurisco Pharmaceutical Co Ltd
The stock symbol (or 'ticker') for Aurisco Pharmaceutical Co Ltd is "605116."
What Stock Exchange Does Aurisco Pharmaceutical Co Ltd Trade On?
Aurisco Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is Aurisco Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Aurisco Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Aurisco Pharmaceutical Co Ltd share price performance charts on this page. Our technical summary section provides analysis on Aurisco Pharmaceutical Co share price buy/sell indicators using real-time data (or discuss the Aurisco Pharmaceutical Co (605116) stock price today with other investors in the Aurisco Pharmaceutical Co SS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SS 605116 share price (ISIN: CNE1000042S4) to enhance your trading decisions with our free investment tools and resources.
What Is the Aurisco Pharmaceutical Co Ltd Share Price Today?
The Aurisco Pharmaceutical Co share price today is 26.72.
What Is the Stock Symbol for Aurisco Pharmaceutical Co Ltd
The stock symbol (or 'ticker') for Aurisco Pharmaceutical Co Ltd is "605116."
What Stock Exchange Does Aurisco Pharmaceutical Co Ltd Trade On?
Aurisco Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is Aurisco Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Aurisco Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Shanghai
Currency in CNY
26.72
+0.45(+1.71%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.75
26.80
52 wk Range
20.18
35.58
605116 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.7526.80
52 wk Range
20.1835.58
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.09%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.09%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
605116 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
28.00
Upside
+4.79%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Aurisco Pharmaceutical Co.,Ltd. engages in the research, development, production and sales of special complex APIs, pharmaceutical intermediates and preparations worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs. It also provides dexamethasone is used to treat skin diseases; fluticasone propionate preparations are used to treat asthma and allergic rhinitis; fluticasone furoate preparations are used to treat asthma, allergic rhinitis, and chronic obstructive pulmonary disease; eplerenone preparations are used for the treatment of hypertension and heart failure; bepedalic acid preparations are used for the treatment of hypercholesterolemia or atherosclerotic cardiovascular diseases; tenofovir used for the treatment of HIV-1 infection and chronic hepatitis B; pregabalin preparations are used to treat neuropathic pain, fibromyalgia, epilepsy, etc.; brivaracetam preparations are used to treat epilepsy; abiraterone acetate and enzalutamide preparation preparations for the treatment of prostate cancer; and dydrogesterone preparations are used to treat dysmenorrhea, endometriosis, irregular menstrual cycle, etc. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.
Compare 605116 to Peers and Sector
Metrics to compare | 605116 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship605116PeersSector | |
|---|---|---|---|---|
P/E Ratio | 23.9x | 22.7x | −0.4x | |
PEG Ratio | 1.01 | 1.11 | 0.00 | |
Price/Book | 4.0x | 2.9x | 2.6x | |
Price / LTM Sales | 6.3x | 4.4x | 3.2x | |
Upside (Analyst Target) | 6.1% | 32.3% | 45.4% | |
Fair Value Upside | Unlock | 18.6% | 7.0% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 28.00
(+4.79% Upside)
Earnings
Latest Release
17/04/2026
EPS / Forecast
0.23 / --
Revenue / Forecast
460.42M / --
People Also Watch
FAQ
What Is the Aurisco Pharmaceutical Co (605116) Share Price Today?
The Aurisco Pharmaceutical Co stock price today is 26.72 CNY.
What Stock Exchange Does Aurisco Pharmaceutical Co (605116) Trade On?
Aurisco Pharmaceutical Co is listed and trades on the Shanghai Stock Exchange.
What Is the Ticker (Stock Symbol) for Aurisco Pharmaceutical Co?
The stock symbol (also called a 'ticker') for Aurisco Pharmaceutical Co is "605116."
Does Aurisco Pharmaceutical Co Pay Dividends? What’s The Current 605116 Dividend Yield?
Yes, 605116 Pays Dividends to its Shareholders. The current Aurisco Pharmaceutical Co dividend yield is 1.09%.
What Is the Current Aurisco Pharmaceutical Co Market Cap?
As of today, Aurisco Pharmaceutical Co market cap is 10.85B CNY.
What Is Aurisco Pharmaceutical Co's (605116) Earnings Per Share (TTM)?
The Aurisco Pharmaceutical Co EPS is currently 1.10 (Trailing Twelve Months).
When Is the Next Aurisco Pharmaceutical Co Earnings Date?
Aurisco Pharmaceutical Co's next earnings report will be released on 24/04/2026.
Is 605116 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Aurisco Pharmaceutical Co moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Aurisco Pharmaceutical Co Stock Split?
Aurisco Pharmaceutical Co has split 0 times. (See the 605116 stock split history page for full effective split date and price information.)
How Many Employees Does Aurisco Pharmaceutical Co Have?
Aurisco Pharmaceutical Co has 1784 employees.
What is the current trading status of Aurisco Pharmaceutical Co (605116)?
As of 22/04/2026, Aurisco Pharmaceutical Co (605116) is trading at a price of 26.72 CNY, with a previous close of 26.27 CNY. The stock has fluctuated within a day range of 25.75 CNY to 26.80 CNY, while its 52-week range spans from 20.18 CNY to 35.58 CNY.
What Is Aurisco Pharmaceutical Co (605116) Price Target According to Analysts?
The average 12-month price target for Aurisco Pharmaceutical Co is 28.00 CNY, with a high estimate of 28 CNY and a low estimate of 28 CNY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +4.79% Upside potential.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.